Squamous Cell Carcinoma — Trials

Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

2,930 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 977
Recruiting: 518
Ph III recruiting: 60
Growth YoY: +43.1%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (401)

clinicaltrialsPublishedShowing 501–550 of 1,120 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05600842	De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx	recruiting	—	111	University of California, IrvineOTHER	1	May 5, 2026	clinicaltrials
NCT07567313	Stage IV Lung Squamous Cell Carcinoma Treated With or Without Bronchial Artery Chemoembolization After First-line Chemotherapy and Immunotherapy	not yet recruiting	Phase 4	166	Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER